4.5 Article

Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance

期刊

FEBS LETTERS
卷 579, 期 3, 页码 609-614

出版社

WILEY
DOI: 10.1016/j.febslet.2004.12.027

关键词

leukaemia inhibitory factor; axotrophin; immune regulation

资金

  1. NICHD NIH HHS [HD29471] Funding Source: Medline
  2. NIGMS NIH HHS [GM077507-18] Funding Source: Medline
  3. NIMH NIH HHS [MH11560] Funding Source: Medline

向作者/读者索取更多资源

Axotrophin (axot) is a newly characterised stem cell gene and mice that lack axotrophin are viable and fertile, but show premature neural degeneration and defective development of the corpus callosum. By comparing axot(+/+) axot(+/-) and axot(-/-) littermates, we now show that axotrophin is also involved in immune regulation. Both T cell proliferation and T cell-derived leukaemia inhibitory factor (LIF) were suppressed by axotrophin in a gene-dose-dependent manner. Moreover, a role for axotrophin in the feedback regulation of LIF is implicated. This is the first evidence that fate determination mediated by LIF maybe qualified by axotrophin. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据